Results 161 to 170 of about 182,114 (282)

Botulinum toxin

Indian Journal of Dermatology, Venereology and Leprology, 2008
openaire   +2 more sources

Anterior Drooling Versus Posterior Drooling: A Comparative Analysis

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aims To examine the patient population of a tertiary Interdisciplinary Saliva Control Clinic, describe management pathways and identify patients suitable for primary care. Methods Retrospective single‐centre cohort study in a tertiary hospital reviewing patients referred to the Saliva Control Clinic over a 5‐year period.
Kaitlin Duell, Eric Levi, Will Alexander, David Chong, Monica S. Cooper   +4 more
wiley   +1 more source

The Stomatognathic System as an Expanding Frontier for Botulinum Toxin Therapy. [PDF]

Toxins (Basel)
Yoshida K.
europepmc   +1 more source

Characterization of a mosquitocidal botulinum toxin-like neurotoxin complex

reservedParaclostridial mosquitocidal protein 1 (PMP1), a botulinum-like toxin from Paraclostridium bifermentans, belongs to the clostridial neurotoxin (CNT) family, which includes botulinum and tetanus neurotoxins.
ANTONELLO, MARTA
core  

Evaluation of the cost per patient per injection of botulinum toxin A in upper limb spasticity: comparison of two preparations in 19 countries

, 2012
Stéphane Roze,1 Hannah Kurth,2 Barnaby Hunt,3 William Valentine,3 Rémi Marty11HEVA, Lyon, France; 2Ipsen Pharma, Boulogne-Billancourt, France; 3Ossian Health Economics and Communications, Basel, SwitzerlandBackground: Botulinum ...
Kurth H, Hunt B, Valentine W, Marty R, Roze S   +4 more
core  

Gastrocnemius muscle properties in children with cerebral palsy: An exploratory cross‐sectional study of variability in gastrocnemius properties

Experimental Physiology, EarlyView.
Abstract Muscle strength is a key predictor of physical functioning, yet the influence of patient and treatment factors on muscle properties in young people with cerebral palsy is not fully known. We explored whether medial gastrocnemius properties vary by age, ambulatory status and spasticity treatment (botulinum toxin or selective dorsal rhizotomy ...
Elizabeth R. Boyer, Christiana J. Raymond‐Pope, Daniel B. Hoffman, Marshall H. Taniguchi, Tom F. Novacheck, Braydon A. Crum, Peter D. Kim, Sarah M. Greising   +7 more
wiley   +1 more source

Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives To review the evidence base, evolution, outcomes, adverse events (AEs), and management for third‐space endoscopy (TSE) procedures for management of benign motility disorders. Methods This review examines TSE procedures for motility disorders, reviewing the current available techniques, success, outcomes, and long‐term outcomes from ...
Sanjana Bhagwat, Amol Bapaye
wiley   +1 more source

Seven-Site Facial Contouring with Botulinum Toxin Alone: A Practical Framework. [PDF]

Toxins (Basel)
Chung WK, Kim MJ.
europepmc   +1 more source

Successful treatment of Hailey–Hailey disease (HHD) with the IL‐13 inhibitor lebrikizumab

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Elena Schneider, Maike M. Holtsche, Ulrike Raap, Nikolaos Patsinakidis   +3 more
wiley   +1 more source

Predictive Contribution of Clinical Measures of Ankle Neuromuscular Impairments to Ankle Kinematic Deviations During Gait in Children With Cerebral Palsy

Journal of Foot and Ankle Research, Volume 19, Issue 4, December 2026.
ABSTRACT Introductions Children with cerebral palsy (CP) commonly exhibit neuromuscular impairments that affect ankle motion during gait. These include hypertonia, muscle weakness, poor selective motor control, and restricted range‐of‐motion. However, their individual and combined impacts on sagittal ankle kinematics remain unclear. This study aimed to
Faustyna Manikowska, Sabina Brazevic, Brian Po‐Jung Chen, Marek Jóźwiak, Maria K. Lebiedowska   +4 more
wiley   +1 more source